Respiratory
Respiratory drugs and is a growing sector of the pharmaceuticals industry, and we have all the information resources that you need to be a leading player in this lucrative market. The publications listed under Research and Markets’ Respiratory category cover all drugs and therapeutics for conditions and diseases relating to the lungs and/or breathing, such as Acute Respiratory Distress Syndrome (ARDS), allergy, asthma, bronchitis, COPD (chronic obstructive pulmonary disease), cystic fibrosis,
emphysema, lung disease, pneumonia, sinus infections, sleep apnea and others.
Our reports, books, and subscriptions will provide you with the latest industry news, forecasts, market trends and company profiles of market leaders and niche players including: Accentia Biopharmaceuticals, Aerogen, Aerovance, airPharma, AstraZeneca, Aventis Pharma, Bespak, Boehringer Ingelheim Pharmaceuticals, Cadila Pharmaceuticals, Dr. Reddys Laboratories, EvoGenix, GlaxoSmithKlineInyx, The Merck Generics Group, Novartis AG, Pfizer, Ranbaxy Laboratories, Respironics, Sandoz International, Schering-Plough, etc.
Publications on smoking cessation are listed under the OTC sub-category in the Pharmaceuticals section.
Show Less
Read more
Respiratory Tract Infections - Pipeline Review, H2 2012
Respiratory Tract Infections – Pipeline Review, H2 2012
Summary
Global Markets Direct’s, 'Respiratory Tract Infections - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic...
November
2012
FROM
EUR 1,530USD 2,000GBP 1,289AUD 2,128JPY 195,871SEK 13 243CHF 1'882CAD 2,080
Pleural Disease - Pipeline Review, H2 2012
Pleural Disease – Pipeline Review, H2 2012
Summary
Global Markets Direct’s, 'Pleural Disease - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report...
November
2012
FROM
EUR 1,530USD 2,000GBP 1,289AUD 2,128JPY 195,871SEK 13 243CHF 1'882CAD 2,080
Bronchiolitis Obliterans - Pipeline Review, H2 2012
Bronchiolitis Obliterans – Pipeline Review, H2 2012
Summary
Global Markets Direct’s, 'Bronchiolitis Obliterans - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline....
November
2012
FROM
EUR 1,530USD 2,000GBP 1,289AUD 2,128JPY 195,871SEK 13 243CHF 1'882CAD 2,080
Bacterial Respiratory Tract Infections - Pipeline Review, H2 2012
Bacterial Respiratory Tract Infections – Pipeline Review, H2 2012
Summary
Global Markets Direct’s, 'Bacterial Respiratory Tract Infections - Pipeline Review, H2 2012', provides an overview of the...
November
2012
FROM
EUR 1,530USD 2,000GBP 1,289AUD 2,128JPY 195,871SEK 13 243CHF 1'882CAD 2,080
Respiratory Tract Inflammatory Disorders - Pipeline Review, H2 2012
Respiratory Tract Inflammatory Disorders – Pipeline Review, H2 2012
Summary
Global Markets Direct’s, 'Respiratory Tract Inflammatory Disorders - Pipeline Review, H2 2012', provides an overview of...
November
2012
FROM
EUR 1,912USD 2,500GBP 1,611AUD 2,660JPY 244,838SEK 16 554CHF 2'352CAD 2,600
Pulmonary Fibrosis - Pipeline Review, H2 2012
Pulmonary Fibrosis – Pipeline Review, H2 2012
Summary
Global Markets Direct’s, 'Pulmonary Fibrosis - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This...
November
2012
FROM
EUR 1,530USD 2,000GBP 1,289AUD 2,128JPY 195,871SEK 13 243CHF 1'882CAD 2,080
Allergic Asthma - Pipeline Review, H2 2012
Allergic Asthma – Pipeline Review, H2 2012
Summary
Global Markets Direct’s, 'Allergic Asthma - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report...
November
2012
FROM
EUR 1,530USD 2,000GBP 1,289AUD 2,128JPY 195,871SEK 13 243CHF 1'882CAD 2,080
Bronchitis Global Clinical Trials Review, H2, 2012
Summary
Our clinical trial report, “Bronchitis Global Clinical Trials Review, H2, 2012" provides data on the Bronchitis clinical trial scenario....
November
2012
FROM
EUR 1,912USD 2,500GBP 1,611AUD 2,660JPY 244,838SEK 16 554CHF 2'352CAD 2,600
Chronic Obstructive Pulmonary Disease (COPD) Global Clinical Trials Review, H2, 2012
Summary
Our clinical trial report, “Chronic Obstructive Pulmonary Disease (COPD) Global Clinical Trials Review,...
November
2012
FROM
EUR 1,912USD 2,500GBP 1,611AUD 2,660JPY 244,838SEK 16 554CHF 2'352CAD 2,600
Diphtheria Global Clinical Trials Review, H2, 2012
Summary
Our clinical trial report, “Diphtheria Global Clinical Trials Review, H2, 2012" provides data on the Diphtheria clinical trial scenario....
November
2012
FROM
EUR 1,912USD 2,500GBP 1,611AUD 2,660JPY 244,838SEK 16 554CHF 2'352CAD 2,600
Allergic Rhinitis Global Clinical Trials Review, H2, 2012
Summary
Our clinical trial report, “Allergic Rhinitis Global Clinical Trials Review, H2, 2012" provides data on the Allergic Rhinitis clinical...
November
2012
FROM
EUR 1,912USD 2,500GBP 1,611AUD 2,660JPY 244,838SEK 16 554CHF 2'352CAD 2,600
Bronchopulmonary Dysplasia - Pipeline Review, H2 2012
Bronchopulmonary Dysplasia – Pipeline Review, H2 2012
Summary
Global Markets Direct’s, 'Bronchopulmonary Dysplasia - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic...
October
2012
FROM
EUR 1,530USD 2,000GBP 1,289AUD 2,128JPY 195,871SEK 13 243CHF 1'882CAD 2,080
Lung Injury - Pipeline Review, H2 2012
Lung Injury – Pipeline Review, H2 2012
Summary
Global Markets Direct’s, 'Lung Injury - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides...
October
2012
FROM
EUR 1,530USD 2,000GBP 1,289AUD 2,128JPY 195,871SEK 13 243CHF 1'882CAD 2,080
Cystic Fibrosis - Pipeline Review, H2 2012
Cystic Fibrosis – Pipeline Review, H2 2012
Summary
Global Markets Direct’s, 'Cystic Fibrosis - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report...
October
2012
FROM
EUR 1,530USD 2,000GBP 1,289AUD 2,128JPY 195,871SEK 13 243CHF 1'882CAD 2,080
Diphtheria - Pipeline Review, H2 2012
Diphtheria – Pipeline Review, H2 2012
Summary
Global Markets Direct’s, 'Diphtheria - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides...
October
2012
FROM
EUR 1,530USD 2,000GBP 1,289AUD 2,128JPY 195,871SEK 13 243CHF 1'882CAD 2,080
Bronchiolitis - Pipeline Review, H2 2012
Bronchiolitis – Pipeline Review, H2 2012
Summary
Global Markets Direct’s, 'Bronchiolitis - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides...
October
2012
FROM
EUR 1,530USD 2,000GBP 1,289AUD 2,128JPY 195,871SEK 13 243CHF 1'882CAD 2,080
Acute Lung Injury Global Clinical Trials Review, H2, 2012
Summary
Our clinical trial report, “Acute Lung Injury Global Clinical Trials Review, H2, 2012" provides data on the Acute Lung Injury clinical...
October
2012
FROM
EUR 1,912USD 2,500GBP 1,611AUD 2,660JPY 244,838SEK 16 554CHF 2'352CAD 2,600
Respiratory Insufficiency Global Clinical Trials Review, H2, 2012
Summary
Our clinical trial report, “Respiratory Insufficiency Global Clinical Trials Review, H2, 2012" provides data on the Respiratory...
October
2012
FROM
EUR 1,912USD 2,500GBP 1,611AUD 2,660JPY 244,838SEK 16 554CHF 2'352CAD 2,600
Emphysema Global Clinical Trials Review, H2, 2012
Summary
Our clinical trial report, “Emphysema Global Clinical Trials Review, H2, 2012" provides data on the Emphysema clinical trial scenario. This...
October
2012
FROM
EUR 1,912USD 2,500GBP 1,611AUD 2,660JPY 244,838SEK 16 554CHF 2'352CAD 2,600
Strategic Analysis of the North American Respiratory Protection Market 2012
Strategic Analysis of the North American Respiratory Protection Market 2012 - The Search for a New Growth Pipeline This study provides a 360-degree perspective on the 2011 North American market for...
October
2012
FROM
EUR 4,589USD 6,000GBP 3,867AUD 6,385JPY 587,612SEK 39 730CHF 5'646CAD 6,239